Supriya Lifescience Ltd reported a 21.7% increase in revenue for Q1 FY25, reaching Rs. 160.63 crore, with a Profit After Tax of Rs. 44.64 crore and EBITDA rising by 40.6% to Rs. 62.54 crore, reflecting significant growth and improved profit margins.
AI Assistant
Supriya Lifescience Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.